AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 71 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $21,000 | -25.0% | 33,400 | 0.0% | 0.00% | – |
| Q3 2019 | $28,000 | +27.3% | 33,400 | 0.0% | 0.00% | – |
| Q2 2019 | $22,000 | -51.1% | 33,400 | -39.2% | 0.00% | – |
| Q1 2019 | $45,000 | -48.9% | 54,959 | 0.0% | 0.00% | – |
| Q4 2018 | $88,000 | -51.6% | 54,959 | 0.0% | 0.00% | – |
| Q3 2018 | $182,000 | +46.8% | 54,959 | 0.0% | 0.00% | – |
| Q2 2018 | $124,000 | +27.8% | 54,959 | +64.5% | 0.00% | – |
| Q1 2018 | $97,000 | -77.4% | 33,400 | -78.3% | 0.00% | -100.0% |
| Q4 2017 | $429,000 | +251.6% | 153,845 | +360.6% | 0.00% | – |
| Q3 2017 | $122,000 | +64.9% | 33,400 | 0.0% | 0.00% | – |
| Q2 2017 | $74,000 | +270.0% | 33,400 | 0.0% | 0.00% | – |
| Q1 2017 | $20,000 | +11.1% | 33,400 | 0.0% | 0.00% | – |
| Q4 2016 | $18,000 | -40.0% | 33,400 | 0.0% | 0.00% | – |
| Q3 2016 | $30,000 | -6.2% | 33,400 | 0.0% | 0.00% | – |
| Q2 2016 | $32,000 | +3.2% | 33,400 | 0.0% | 0.00% | – |
| Q1 2016 | $31,000 | -26.2% | 33,400 | 0.0% | 0.00% | – |
| Q4 2015 | $42,000 | +5.0% | 33,400 | 0.0% | 0.00% | – |
| Q3 2015 | $40,000 | -31.0% | 33,400 | 0.0% | 0.00% | – |
| Q2 2015 | $58,000 | -83.6% | 33,400 | -91.0% | 0.00% | – |
| Q1 2015 | $354,000 | 0.0% | 369,200 | 0.0% | 0.00% | – |
| Q4 2014 | $354,000 | -13.7% | 369,200 | 0.0% | 0.00% | -100.0% |
| Q3 2014 | $410,000 | -18.2% | 369,200 | +34.8% | 0.00% | 0.0% |
| Q2 2014 | $501,000 | +21.3% | 273,900 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $413,000 | +650.9% | 273,900 | +720.1% | 0.00% | – |
| Q4 2013 | $55,000 | -24.7% | 33,400 | -4.8% | 0.00% | – |
| Q3 2013 | $73,000 | +62.2% | 35,100 | +93.9% | 0.00% | – |
| Q2 2013 | $45,000 | – | 18,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greylock XI GP Limited Partnership | 584,004 | $1,068,000 | 100.00% |
| GREAT POINT PARTNERS LLC | 2,325,000 | $4,255,000 | 1.89% |
| Sarissa Capital Management LP | 2,570,759 | $4,704,000 | 1.60% |
| Deer VI & Co. LLC | 675,242 | $1,236,000 | 0.68% |
| Palo Alto Investors LP | 1,200,800 | $2,197,000 | 0.16% |
| Baupost Group | 3,829,350 | $7,008,000 | 0.11% |
| Gruss Capital Management LP | 533,253 | $976,000 | 0.05% |
| Granahan Investment Management | 676,451 | $1,238,000 | 0.04% |
| Fore Research & Management, LP | 674,200 | $1,233,000 | 0.04% |
| TFS CAPITAL LLC | 210,369 | $385,000 | 0.03% |